Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on June 6, 2025
Nasal Sprays Market to Expand from USD 15.82 Billion in 2025
EIN Presswire
·
June 6, 2025
Nasal Sprays Market Shows Strong Potential Amid Health Awareness NEW YORK, DE, UNITED STATES, June 6, 2025 /EINPresswire.com/ -- The global nasal sprays market is projected to grow from USD 15.82 billion in 2025 to USD 28.35 billion by 2035, expanding …
Immix Biopharma Attends FDA CEO Forum in Washington DC
GlobeNewswire
·
June 6, 2025
– Selected to Attend In-Person Event on June 5 led by FDA Commissioner Marty A. Makary, M.D., M.P.H. – LOS ANGELES, CA, June 06, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage …
Soligenix Highlights Dr. Ellen Kim’s Recent Q&A and the Promise of HyBryte™ in Ongoing Clinical Trials
GlobeNewswire
·
June 6, 2025
PRINCETON, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- via IBN – Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet …
Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair
GlobeNewswire
·
June 6, 2025
Mr. Chin brings over 20 years of financial experience across public and private healthcare organizations Mr. Chin currently serves as CFO of Akido Labs where he successfully helped raise $60 million in a recent financing Mr. Chin’s appointment strengthens …
Apellis and Sobi Announce EMPAVELI® (pegcetacoplan) Showed Sustained Efficacy at One Year in Phase 3 Study for C3G and Primary IC-MPGN
GlobeNewswire
·
June 6, 2025
Robust proteinuria reduction and stable kidney function were maintained across a broad population of patients No new safety signals were observed New data presented at late-breaking session at the European Renal Association Congress Marketing applications …
JBDI Holdings Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
GlobeNewswire
·
June 6, 2025
Receives Notice of Failure to File Interim Financial Statements in Violation of Nasdaq Listing Rules SINGAPORE, June 06, 2025 (GLOBE NEWSWIRE) -- JBDI Holdings Limited (“JBDI” or the “Company”) (Nasdaq: JBDI), today announced that it has received notice ( …
Senti Bio to Participate in a Virtual Fireside Chat Hosted by Chardan Capital Markets, LLC
GlobeNewswire
·
June 6, 2025
SOUTH SAN FRANCISCO, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene …
Renault Group finalises a strategic partnership with Wandercraft, a leader in next generation robotics
GlobeNewswire
·
June 6, 2025
Renault Group announces the closing of the acquisition of a minority investment in Wandercraft, a French company with an undisputed leadership in AI-enabled robotic exoskeletons for people with reduced mobility, currently deploying its technology towards …
NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs
GlobeNewswire
·
June 6, 2025
USC brain tumor authority to accelerate four clinical trials including lead asset NEO100 nearing Phase 2a completion ahead of schedule Appointment bolsters FDA approval path while company explores AI and quantum computing to enhance drug delivery platform …
LEX Diagnostics Submits Dual Applications for FDA 510(k) Clearance and CLIA Waiver for Groundbreaking LEX VELO System
GlobeNewswire
·
June 6, 2025
CAMBRIDGESHIRE, United Kingdom, June 06, 2025 (GLOBE NEWSWIRE) -- LEX Diagnostics, a leading innovator in molecular diagnostics, has submitted dual applications to the U.S. Food and Drug Administration (FDA) seeking 510(k) clearance and CLIA waived status …
Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus
GlobeNewswire
·
June 6, 2025
SOUTH SAN FRANCISCO, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune disease, today announced the appointment of …
Ultrahuman Home: The Future of Healthy Living is here
GlobeNewswire
·
June 6, 2025
London, June 06, 2025 (GLOBE NEWSWIRE) -- Ultrahuman today announced the public launch of Ultrahuman Home, a groundbreaking home health monitoring device that redefines how we experience and optimize our living spaces. Available now on Ultrahuman.com, …
Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami
GlobeNewswire
·
June 6, 2025
REYKJAVIK, Iceland, June 06, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Goldman Sachs …
Sleep Apnea Devices Market worth US$9.3 billion by 2029 | MarketsandMarkets™.
GlobeNewswire
·
June 6, 2025
Delray Beach, FL, June 06, 2025 (GLOBE NEWSWIRE) -- The global sleep apnea devices market valued at US$6.0 billion in 2023, stood at US$6.5 billion in 2024 and is projected to advance at a resilient CAGR of 7.3% from 2024 to 2029, culminating in a …
Candel Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors
GlobeNewswire
·
June 6, 2025
NEEDHAM, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …
Celldex Therapeutics Announces Election of Denice Torres to its Board of Directors
GlobeNewswire
·
June 6, 2025
HAMPTON, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that Denice M. Torres has been elected to the company’s Board of Directors. "We are excited to welcome Denice to the Celldex Board of Directors," said …
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 6, 2025
DALLAS, June 06, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the …
Spur Therapeutics Presents Positive New Preclinical Data on Its Gene Therapy Candidate for GBA1 Parkinson’s Disease at 2025 GBA1 Meeting
GlobeNewswire
·
June 6, 2025
Data show SPR301 lowered α-synuclein, a hallmark of Parkinson’s disease, in cellular models, indicating potential for efficacy at doses with favorable safety Demonstrated greater α-synuclein reductions compared to other gene therapy approaches LONDON, June …
Arcutis to Present New Long-Term Results of ZORYVE® (roflumilast) Cream at the 2025 Revolutionizing Atopic Dermatitis Conference
GlobeNewswire
·
June 6, 2025
New data from the Phase 3 INTEGUMENT-OLE long-term open label study show durable improvement in the signs and symptoms of atopic dermatitis (AD), including almost half of participants achieving no or minimal itch with ZORYVE cream 0.15% or ZORYVE cream 0. …
PetVivo and Commonwealth Partner to Advance Equine Wellness Across Thoroughbred Racing
GlobeNewswire
·
June 6, 2025
Minneapolis, MN, June 06, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), an emerging biomedical device company focused on animal health, today announced a strategic collaboration with Commonwealth, the syndicated ownership …